Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Trevi Therapeutics, Inc. | 45,000 | reported | 11 Jun 2025 | tx 12+228,877−155,784 |
| BARRIER THERAPEUTICS INC | 30,000 | reported | 14 Mar 2008 | tx 8+146,000 |
| Vaxart, Inc. | 12,700 | reported | 12 Jun 2019 | tx 9+161,700 |
| Traws Pharma, Inc. | 10,000 | reported | 15 Jun 2015 | tx 4+50,000 |
| QLT INC/BC | 9,600 | reported | 22 Dec 2016 | tx 2+13,702 |
| INTEGRA LIFESCIENCES HOLDINGS CORP | 8,478 | reported | 17 May 2012 | tx 12+61,960−12,770 |
| APPLIED GENETIC TECHNOLOGIES CORP | 0 | reported | 30 Nov 2022 | tx 15+88,000−80,000 |
| PENWEST PHARMACEUTICALS CO | 0 | reported | 20 Sept 2010 | tx 25+69,628−69,391 |
| I STAT CORPORATION /DE/ | 0 | reported | 28 Jan 2004 | tx 13+25,099−69,462 |
| Aegerion Pharmaceuticals, Inc. | 0 | reported | 29 Nov 2016 | tx 10+41,712−41,712 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Jun 2025 | GRANT_AWARD | Trevi Therapeutics, Inc. | 45,000 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | Trevi Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 28 Jun 2023 | GRANT_AWARD | Trevi Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 30 Nov 2022 | OTHER | APPLIED GENETIC TECHNOLOGIES CORP | 8,000 | — | deriv |
| 30 Nov 2022 | OTHER | APPLIED GENETIC TECHNOLOGIES CORP | 16,000 | — | deriv |
| 30 Nov 2022 | OTHER | APPLIED GENETIC TECHNOLOGIES CORP | 14,000 | — | deriv |
| 30 Nov 2022 | OTHER | APPLIED GENETIC TECHNOLOGIES CORP | 10,000 | — | deriv |
| 30 Nov 2022 | OTHER | APPLIED GENETIC TECHNOLOGIES CORP | 10,000 | — | deriv |
| 30 Nov 2022 | OTHER | APPLIED GENETIC TECHNOLOGIES CORP | 12,000 | — | deriv |
| 30 Nov 2022 | OTHER | APPLIED GENETIC TECHNOLOGIES CORP | 10,000 | — | deriv |
| 23 Jun 2022 | GRANT_AWARD | Trevi Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 30 Nov 2021 | GRANT_AWARD | APPLIED GENETIC TECHNOLOGIES CORP | 14,000 | 0.00 USD | deriv |
| 16 Jun 2021 | GRANT_AWARD | Trevi Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 16 Dec 2020 | GRANT_AWARD | APPLIED GENETIC TECHNOLOGIES CORP | 12,000 | 0.00 USD | deriv |
| 11 Jun 2020 | GRANT_AWARD | Trevi Therapeutics, Inc. | 14,210 | 0.00 USD | deriv |
| 04 Dec 2019 | GRANT_AWARD | APPLIED GENETIC TECHNOLOGIES CORP | 10,000 | 0.00 USD | deriv |
| 12 Jun 2019 | GRANT_AWARD | Vaxart, Inc. | 9,000 | 0.00 USD | deriv |
| 12 Jun 2019 | GRANT_AWARD | Vaxart, Inc. | 12,700 | 0.00 USD | deriv |
| 09 May 2019 | PURCHASE | Trevi Therapeutics, Inc. | 5,000 | 10.00 USD | first after silence |
| 09 May 2019 | CONVERSION | Trevi Therapeutics, Inc. | 20,983 | — | |
| 09 May 2019 | CONVERSION | Trevi Therapeutics, Inc. | 107,977 | 0.00 USD | deriv |
| 09 May 2019 | CONVERSION | Trevi Therapeutics, Inc. | 47,807 | 0.00 USD | deriv |
| 07 May 2019 | GRANT_AWARD | Trevi Therapeutics, Inc. | 23,684 | 0.00 USD | deriv |
| 15 Nov 2018 | GRANT_AWARD | APPLIED GENETIC TECHNOLOGIES CORP | 10,000 | 0.00 USD | deriv |
| 25 Jul 2018 | GRANT_AWARD | APPLIED GENETIC TECHNOLOGIES CORP | 8,000 | 0.00 USD | deriv |
3 purchases reported after at least 12 months of silence — most recent on 09 May 2019.